Skip to main content

Research Repository

Advanced Search

Ink-jet 3D printing as a strategy for developing bespoke non-eluting biofilm resistant medical devices

He, Yinfeng; Luckett, Jeni; Begines, Belen; Dubern, Jean Frédéric; Hook, Andrew L.; Prina, Elisabetta; Rose, Felicity R.A.J.; Tuck, Christopher J.; Hague, Richard J.M.; Irvine, Derek J.; Williams, Paul; Alexander, Morgan R.; Wildman, Ricky D.

Ink-jet 3D printing as a strategy for developing bespoke non-eluting biofilm resistant medical devices Thumbnail


Authors

YINFENG HE Yinfeng.He@nottingham.ac.uk
Transitional Assistant Professor

JENI LUCKETT JENI.LUCKETT@NOTTINGHAM.AC.UK
Senior Research Fellow

Belen Begines

ANDREW HOOK ANDREW.HOOK@NOTTINGHAM.AC.UK
Assistant Professor

Elisabetta Prina

Profile Image

FELICITY ROSE FELICITY.ROSE@NOTTINGHAM.AC.UK
Professor of Biomaterials and Tissue Engineering

CHRISTOPHER TUCK CHRISTOPHER.TUCK@NOTTINGHAM.AC.UK
Professor of Materials Engineering

RICHARD HAGUE RICHARD.HAGUE@NOTTINGHAM.AC.UK
Professor of Additive Manufacturing

DEREK IRVINE derek.irvine@nottingham.ac.uk
Professor of Materials Chemistry

PAUL WILLIAMS PAUL.WILLIAMS@NOTTINGHAM.AC.UK
Professor of Molecular Microbiology

Profile Image

MORGAN ALEXANDER MORGAN.ALEXANDER@NOTTINGHAM.AC.UK
Professor of Biomedical Surfaces

RICKY WILDMAN RICKY.WILDMAN@NOTTINGHAM.AC.UK
Professor of Multiphase Flow and Mechanics



Abstract

Chronic infection as a result of bacterial biofilm formation on implanted medical devices is a major global healthcare problem requiring new biocompatible, biofilm-resistant materials. Here we demonstrate how bespoke devices can be manufactured through ink-jet-based 3D printing using bacterial biofilm inhibiting formulations without the need for eluting antibiotics or coatings. Candidate monomers were formulated and their processability and reliability demonstrated. Formulations for in vivo evaluation of the 3D printed structures were selected on the basis of their in vitro bacterial biofilm inhibitory properties and lack of mammalian cell cytotoxicity. In vivo in a mouse implant infection model, Pseudomonas aeruginosa biofilm formation on poly-TCDMDA was reduced by ∼99% when compared with medical grade silicone. Whole mouse bioluminescence imaging and tissue immunohistochemistry revealed the ability of the printed device to modulate host immune responses as well as preventing biofilm formation on the device and infection of the surrounding tissues. Since 3D printing can be used to manufacture devices for both prototyping and clinical use, the versatility of ink-jet based 3D-printing to create personalised functional medical devices is demonstrated by the biofilm resistance of both a finger joint prosthetic and a prostatic stent printed in poly-TCDMDA towards P. aeruginosa and Staphylococcus aureus.

Journal Article Type Article
Acceptance Date Dec 27, 2021
Online Publication Date Dec 30, 2021
Publication Date Feb 1, 2022
Deposit Date Jan 7, 2022
Publicly Available Date Jan 20, 2022
Journal Biomaterials
Print ISSN 0142-9612
Electronic ISSN 1878-5905
Publisher Elsevier BV
Peer Reviewed Peer Reviewed
Volume 281
Article Number 121350
DOI https://doi.org/10.1016/j.biomaterials.2021.121350
Keywords Mechanics of Materials; Biomaterials; Biophysics; Ceramics and Composites; Bioengineering
Public URL https://nottingham-repository.worktribe.com/output/7169990
Publisher URL https://www.sciencedirect.com/science/article/pii/S0142961221007067?via%3Dihub

Files





You might also like



Downloadable Citations